Home / Inspections / 1253764

FDA Inspection 1253764 — GSK LLC (GlaxoSmithKline)

GSK LLC (GlaxoSmithKline) — FEI 3006810568

The FDA completed an inspection of GSK LLC (GlaxoSmithKline) on November 22, 2024 in Collegeville, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 22, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Collegeville, PA (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1269601 (NAI Tue Oct 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187325 (NAI Mon Oct 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1180594 (NAI Fri Aug 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 886173 (VAI Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805603 (NAI Thu Nov 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources